Firm to pay Sh830bn for not warning drug causes breast growth in men
Johnson & Johnson challenges ruling, calling the damages awarded “grossly disproportionate” with the initial award in the case of $680,000.
Accessibility Tools
Johnson & Johnson challenges ruling, calling the damages awarded “grossly disproportionate” with the initial award in the case of $680,000.